Peng-Jun Lu1, Alissa O'Halloran2, Helen Ding3, Anup Srivastav2, Walter W Williams4. 1. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Ga. Electronic address: lhp8@cdc.gov. 2. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Ga; Leidos Inc, Atlanta, Ga. 3. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Ga; Eagle Medical Services LLC, San Antonio, Tex. 4. Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Ga.
Abstract
BACKGROUND: Since 1960, the Advisory Committee on Immunization Practices has recommended influenza vaccination for adults with certain high-risk conditions because of increased risk for complications from influenza infection. We assessed national influenza vaccination among persons ages 18-64 years with high-risk conditions. METHODS: We analyzed data from the 2012 and 2013 National Health Interview Survey. The Kaplan-Meier survival analysis procedure was used to estimate the cumulative proportion of influenza vaccination among adults ages 18-64 years with high-risk conditions. Potential missed opportunities for influenza vaccination were also evaluated. Multivariable logistic regression and predictive marginal analyses were conducted to identify factors independently associated with vaccination. RESULTS: Overall, 39.9 million adults ages 18-64 years (18.9%) had at least one high-risk condition. For adults ages 18-64 years with high-risk conditions, overall influenza vaccination coverage was 49.5%. Coverage among adults 50-64 years of age was significantly higher compared with those ages 18-49 years (59.3% vs 39.0%; P <.05). Among adults ages 18-64 years, coverage was 46.2% for those with chronic lung diseases, 50.5% for those with heart disease, 58.0% for those with diabetes, 62.5% for those with renal disease, and 56.4% for those with cancer. Overall, 90.1% reported at least one visit to a health care setting where vaccination could have been provided. Among adults ages 18-64 years with high-risk conditions, older age, being female, Hispanic ethnicity or Asian race, having one or more physician visits, a regular physician for health care, health insurance, and having ever received pneumococcal vaccination were independently associated with a higher likelihood of influenza vaccination. Being widowed/divorced/separated or never married and not being employed were independently associated with a lower likelihood of influenza vaccination. CONCLUSIONS: Influenza vaccination coverage varies substantially by age and high-risk conditions but remains low. Approximately 50% of those with high-risk conditions remain unvaccinated. Health care providers should ensure they routinely assess influenza vaccination status, and recommend and offer vaccines to those with high-risk conditions. Published by Elsevier Inc.
BACKGROUND: Since 1960, the Advisory Committee on Immunization Practices has recommended influenza vaccination for adults with certain high-risk conditions because of increased risk for complications from influenza infection. We assessed national influenza vaccination among persons ages 18-64 years with high-risk conditions. METHODS: We analyzed data from the 2012 and 2013 National Health Interview Survey. The Kaplan-Meier survival analysis procedure was used to estimate the cumulative proportion of influenza vaccination among adults ages 18-64 years with high-risk conditions. Potential missed opportunities for influenza vaccination were also evaluated. Multivariable logistic regression and predictive marginal analyses were conducted to identify factors independently associated with vaccination. RESULTS: Overall, 39.9 million adults ages 18-64 years (18.9%) had at least one high-risk condition. For adults ages 18-64 years with high-risk conditions, overall influenza vaccination coverage was 49.5%. Coverage among adults 50-64 years of age was significantly higher compared with those ages 18-49 years (59.3% vs 39.0%; P <.05). Among adults ages 18-64 years, coverage was 46.2% for those with chronic lung diseases, 50.5% for those with heart disease, 58.0% for those with diabetes, 62.5% for those with renal disease, and 56.4% for those with cancer. Overall, 90.1% reported at least one visit to a health care setting where vaccination could have been provided. Among adults ages 18-64 years with high-risk conditions, older age, being female, Hispanic ethnicity or Asian race, having one or more physician visits, a regular physician for health care, health insurance, and having ever received pneumococcal vaccination were independently associated with a higher likelihood of influenza vaccination. Being widowed/divorced/separated or never married and not being employed were independently associated with a lower likelihood of influenza vaccination. CONCLUSIONS: Influenza vaccination coverage varies substantially by age and high-risk conditions but remains low. Approximately 50% of those with high-risk conditions remain unvaccinated. Health care providers should ensure they routinely assess influenza vaccination status, and recommend and offer vaccines to those with high-risk conditions. Published by Elsevier Inc.
Authors: Anthony E Fiore; Timothy M Uyeki; Karen Broder; Lyn Finelli; Gary L Euler; James A Singleton; John K Iskander; Pascale M Wortley; David K Shay; Joseph S Bresee; Nancy J Cox Journal: MMWR Recomm Rep Date: 2010-08-06
Authors: Richard Kent Zimmerman; Mahlon Raymund; Janine E Janosky; Mary Patricia Nowalk; Michael J Fine Journal: Vaccine Date: 2003-03-28 Impact factor: 3.641
Authors: Alan Silver; James Figge; Donna L Haskin; Veronica Pryor; Karen Fuller; Thomas Lemme; Nancy Li; Mary Jane O'Brien Journal: J Community Health Date: 2011-04
Authors: Mary Patricia Nowalk; Krissy K Moehling; Song Zhang; Jonathan M Raviotta; Richard K Zimmerman; Chyongchiou J Lin Journal: Am J Manag Care Date: 2017-11 Impact factor: 2.229
Authors: Sujatha Changolkar; Charles A L Rareshide; Christopher K Snider; Mitesh S Patel Journal: J Gen Intern Med Date: 2019-05-06 Impact factor: 5.128
Authors: Peng-Jun Lu; Alissa O'Halloran; Erin D Kennedy; Walter W Williams; David Kim; Amy Parker Fiebelkorn; Sara Donahue; Carolyn B Bridges Journal: Vaccine Date: 2017-04-28 Impact factor: 3.641
Authors: Jill A Dever; Ashley Amaya; Anup Srivastav; Peng-Jun Lu; Jessica Roycroft; Marshica Stanley; M Christopher Stringer; Michael G Bostwick; Stacie M Greby; Tammy A Santibanez; Walter W Williams Journal: J Surv Stat Methodol Date: 2021-06
Authors: Samantha M Harrison; Melissa Y Wei; Lois E Lamerato; Joshua G Petrie; Emily Toth Martin Journal: Vaccine Date: 2018-05-07 Impact factor: 3.641
Authors: Peng-Jun Lu; Mei-Chuan Hung; Alissa C O'Halloran; Helen Ding; Anup Srivastav; Walter W Williams; James A Singleton Journal: Am J Prev Med Date: 2019-08-29 Impact factor: 5.043
Authors: Peng-Jun Lu; Anup Srivastav; Tammy A Santibanez; M Christopher Stringer; Michael Bostwick; Jill A Dever; Marshica Stanley Kurtz; Walter W Williams Journal: Vaccine Date: 2017-07-01 Impact factor: 3.641
Authors: Peng-Jun Lu; Mei-Chuan Hung; Anup Srivastav; Lisa A Grohskopf; Miwako Kobayashi; Aaron M Harris; Kathleen L Dooling; Lauri E Markowitz; Alfonso Rodriguez-Lainz; Walter W Williams Journal: MMWR Surveill Summ Date: 2021-05-14
Authors: Michael J Wu; Jessie R Chung; Sara S Kim; Michael L Jackson; Lisa A Jackson; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Michael Reis; Madhava Beeram; Emily T Martin; Arnold S Monto; Mary Patricia Nowalk; Richard Zimmerman; Tammy A Santibanez; James A Singleton; Manish Patel; Brendan Flannery Journal: Vaccine Date: 2021-02-15 Impact factor: 4.169